{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T22:10:58Z","timestamp":1794003058022,"version":"4.8.0"},"reference-count":143,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2026,8,11]],"date-time":"2026-08-11T00:00:00Z","timestamp":1786406400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,8,11]],"date-time":"2026-08-11T00:00:00Z","timestamp":1786406400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Rev Immunol"],"DOI":"10.1038\/s41577-026-01335-w","type":"journal-article","created":{"date-parts":[[2026,8,11]],"date-time":"2026-08-11T11:33:46Z","timestamp":1786448026000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Immune surveillance and immune evasion of senescent cells"],"prefix":"10.1038","author":[{"ORCID":"https:\/\/orcid.org\/0009-0009-6784-8114","authenticated-orcid":false,"given":"Pau","family":"Garcia-Baucells","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7177-9312","authenticated-orcid":false,"given":"Manuel","family":"Serrano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7654-6216","authenticated-orcid":false,"given":"Corina","family":"Amor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,8,11]]},"reference":[{"key":"1335_CR1","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1016\/S0092-8674(00)81902-9","volume":"88","author":"M Serrano","year":"1997","unstructured":"Serrano, M., Lin, A. W., McCurrach, M. E., Beach, D. & Lowe, S. W. Oncogenic ras provokes premature cell senescence associated with accumulation of p53 and p16INK4a. Cell 88, 593\u2013602 (1997).","journal-title":"Cell"},{"key":"1335_CR2","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1126\/science.279.5349.349","volume":"279","author":"AG Bodnar","year":"1998","unstructured":"Bodnar, A. G. et al. Extension of life-span by introduction of telomerase into normal human cells. Science 279, 349\u2013352 (1998).","journal-title":"Science"},{"key":"1335_CR3","doi-asserted-by":"publisher","first-page":"436","DOI":"10.1016\/j.tcb.2018.02.001","volume":"28","author":"A Hernandez-Segura","year":"2018","unstructured":"Hernandez-Segura, A., Nehme, J. & Demaria, M. Hallmarks of cellular senescence. Trends Cell Biol. 28, 436\u2013453 (2018).","journal-title":"Trends Cell Biol."},{"key":"1335_CR4","doi-asserted-by":"publisher","first-page":"2853","DOI":"10.1371\/journal.pbio.0060301","volume":"6","author":"JP Copp\u00e9","year":"2008","unstructured":"Copp\u00e9, J. P. et al. Senescence-associated secretory phenotypes reveal cell-nonautonomous functions of oncogenic RAS and the p53 tumor suppressor. PLoS Biol. 6, 2853\u20132868 (2008).","journal-title":"PLoS Biol."},{"key":"1335_CR5","doi-asserted-by":"publisher","first-page":"1104","DOI":"10.1016\/j.cell.2013.10.019","volume":"155","author":"D Mu\u00f1oz-Esp\u00edn","year":"2013","unstructured":"Mu\u00f1oz-Esp\u00edn, D. et al. Programmed cell senescence during mammalian embryonic development. Cell 155, 1104\u20131118 (2013).","journal-title":"Cell"},{"key":"1335_CR6","doi-asserted-by":"publisher","first-page":"656","DOI":"10.1038\/nature05529","volume":"445","author":"W Xue","year":"2007","unstructured":"Xue, W. et al. Senescence and tumour clearance is triggered by p53 restoration in murine liver carcinomas. Nature 445, 656\u2013660 (2007). One of the first articles to provide evidence that p53+ senescent cells are cleared by the immune system in vivo.","journal-title":"Nature"},{"key":"1335_CR7","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-018-07825-3","volume":"9","author":"Y Ovadya","year":"2018","unstructured":"Ovadya, Y. et al. Impaired immune surveillance accelerates accumulation of senescent cells and aging. Nat. Commun. 9, 5435 (2018). One of the first articles to explore whether immune dysfunction contributes to the accumulation of senescent cells during natural ageing.","journal-title":"Nat. Commun."},{"key":"1335_CR8","doi-asserted-by":"publisher","first-page":"678","DOI":"10.1038\/s41586-024-07797-z","volume":"633","author":"ASL Chan","year":"2024","unstructured":"Chan, A. S. L. et al. Titration of RAS alters senescent state and influences tumour initiation. Nature 633, 678\u2013685 (2024).","journal-title":"Nature"},{"key":"1335_CR9","doi-asserted-by":"publisher","first-page":"1371","DOI":"10.1126\/science.aax0860","volume":"368","author":"G Desd\u00edn-Mic\u00f3","year":"2020","unstructured":"Desd\u00edn-Mic\u00f3, G. et al. T cells with dysfunctional mitochondria induce multimorbidity and premature senescence. Science 368, 1371\u20131376 (2020).","journal-title":"Science"},{"key":"1335_CR10","doi-asserted-by":"publisher","first-page":"1970","DOI":"10.1038\/s43587-025-00953-8","volume":"5","author":"Y Elyahu","year":"2025","unstructured":"Elyahu, Y. et al. CD4 T cells acquire eomesodermin to modulate cellular senescence and aging. Nat. Aging 5, 1970\u20131982 (2025).","journal-title":"Nat. Aging"},{"key":"1335_CR11","doi-asserted-by":"publisher","first-page":"2652","DOI":"10.1016\/j.cub.2017.07.033","volume":"27","author":"A Hernandez-Segura","year":"2017","unstructured":"Hernandez-Segura, A. et al. Unmasking transcriptional heterogeneity in senescent cells. Curr. Biol. 27, 2652\u20132660.e2654 (2017).","journal-title":"Curr. Biol."},{"key":"1335_CR12","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2021.109441","volume":"36","author":"F Jochems","year":"2021","unstructured":"Jochems, F. et al. The Cancer SENESCopedia: a delineation of cancer cell senescence. Cell Rep. 36, 109441 (2021).","journal-title":"Cell Rep."},{"key":"1335_CR13","doi-asserted-by":"publisher","first-page":"4052","DOI":"10.18632\/aging.102903","volume":"12","author":"ML Idda","year":"2020","unstructured":"Idda, M. L. et al. Survey of senescent cell markers with age in human tissues. Aging 12, 4052\u20134066 (2020).","journal-title":"Aging"},{"key":"1335_CR14","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0009188","volume":"5","author":"JP Copp\u00e9","year":"2010","unstructured":"Copp\u00e9, J. P. et al. A human-like senescence-associated secretory phenotype is conserved in mouse cells dependent on physiological oxygen. PLoS ONE 5, e9188 (2010).","journal-title":"PLoS ONE"},{"key":"1335_CR15","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pbio.3000599","volume":"18","author":"N Basisty","year":"2020","unstructured":"Basisty, N. et al. A proteomic atlas of senescence-associated secretomes for aging biomarker development. PLoS Biol. 18, e3000599 (2020).","journal-title":"PLoS Biol."},{"key":"1335_CR16","doi-asserted-by":"publisher","DOI":"10.1186\/s12964-023-01280-4","volume":"21","author":"Y Oguma","year":"2023","unstructured":"Oguma, Y. et al. Meta-analysis of senescent cell secretomes to identify common and specific features of the different senescent phenotypes: a tool for developing new senotherapeutics. Cell Commun. Signal. 21, 262 (2023).","journal-title":"Cell Commun. Signal."},{"key":"1335_CR17","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1016\/0531-5565(92)90076-C","volume":"27","author":"AJ Millis","year":"1992","unstructured":"Millis, A. J., McCue, H. M., Kumar, S. & Baglioni, C. Metalloproteinase and TIMP-1 gene expression during replicative senescence. Exp. Gerontol. 27, 425\u2013428 (1992).","journal-title":"Exp. Gerontol."},{"key":"1335_CR18","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1055\/s-0037-1613457","volume":"89","author":"J Martens","year":"2003","unstructured":"Martens, J. et al. Aging of stromal-derived human breast fibroblasts might contribute to breast cancer progression. Thromb. Haemost. 89, 393\u2013404 (2003).","journal-title":"Thromb. Haemost."},{"key":"1335_CR19","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1016\/j.cell.2008.06.049","volume":"134","author":"V Krizhanovsky","year":"2008","unstructured":"Krizhanovsky, V. et al. Senescence of activated stellate cells limits liver fibrosis. Cell 134, 657\u2013667 (2008).","journal-title":"Cell"},{"key":"1335_CR20","doi-asserted-by":"publisher","first-page":"3117","DOI":"10.1158\/0008-5472.CAN-06-3452","volume":"67","author":"D Liu","year":"2007","unstructured":"Liu, D. & Hornsby, P. J. Senescent human fibroblasts increase the early growth of xenograft tumors via matrix metalloproteinase secretion. Cancer Res. 67, 3117\u20133126 (2007).","journal-title":"Cancer Res."},{"key":"1335_CR21","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1242\/jcs.01635","volume":"118","author":"S Parrinello","year":"2005","unstructured":"Parrinello, S., Coppe, J. P., Krtolica, A. & Campisi, J. Stromal-epithelial interactions in aging and cancer: senescent fibroblasts alter epithelial cell differentiation. J. Cell Sci. 118, 485\u2013496 (2005).","journal-title":"J. Cell Sci."},{"key":"1335_CR22","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1038\/s41568-019-0222-9","volume":"20","author":"M Fane","year":"2020","unstructured":"Fane, M. & Weeraratna, A. T. How the ageing microenvironment influences tumour progression. Nat. Rev. Cancer 20, 89\u2013106 (2020).","journal-title":"Nat. Rev. Cancer"},{"key":"1335_CR23","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.124716","volume":"5","author":"DP Mu\u00f1oz","year":"2019","unstructured":"Mu\u00f1oz, D. P. et al. Targetable mechanisms driving immunoevasion of persistent senescent cells link chemotherapy-resistant cancer to aging. JCI Insight 5, e124716 (2019).","journal-title":"JCI Insight"},{"key":"1335_CR24","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1016\/j.cell.2020.03.008","volume":"181","author":"M Ruscetti","year":"2020","unstructured":"Ruscetti, M. et al. Senescence-induced vascular remodeling creates therapeutic vulnerabilities in pancreas cancer. Cell 181, 424\u2013441 e421 (2020).","journal-title":"Cell"},{"key":"1335_CR25","doi-asserted-by":"publisher","first-page":"432","DOI":"10.1158\/2159-8290.CD-22-0528","volume":"13","author":"HA Chen","year":"2023","unstructured":"Chen, H. A. et al. Senescence rewires microenvironment sensing to facilitate antitumor immunity. Cancer Discov. 13, 432\u2013453 (2023). This study explores how senescence modulates IFN\u03b3 sensing and antigen presentation by tumour cells.","journal-title":"Cancer Discov."},{"key":"1335_CR26","doi-asserted-by":"publisher","first-page":"958","DOI":"10.1038\/s41580-024-00727-x","volume":"25","author":"B Wang","year":"2024","unstructured":"Wang, B., Han, J., Elisseeff, J. H. & Demaria, M. The senescence-associated secretory phenotype and its physiological and pathological implications. Nat. Rev. Mol. Cell Biol. 25, 958\u2013978 (2024).","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"1335_CR27","doi-asserted-by":"publisher","first-page":"979","DOI":"10.1038\/ncb3397","volume":"18","author":"M Hoare","year":"2016","unstructured":"Hoare, M. et al. NOTCH1 mediates a switch between two distinct secretomes during senescence. Nat. Cell Biol. 18, 979\u2013992 (2016).","journal-title":"Nat. Cell Biol."},{"key":"1335_CR28","doi-asserted-by":"publisher","first-page":"872","DOI":"10.1038\/s43018-023-00553-8","volume":"4","author":"L Chibaya","year":"2023","unstructured":"Chibaya, L. et al. EZH2 inhibition remodels the inflammatory senescence-associated secretory phenotype to potentiate pancreatic cancer immune surveillance. Nat. Cancer 4, 872\u2013892 (2023).","journal-title":"Nat. Cancer"},{"key":"1335_CR29","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1111\/j.1474-9726.2012.00795.x","volume":"11","author":"G Nelson","year":"2012","unstructured":"Nelson, G. et al. A senescent cell bystander effect: senescence-induced senescence. Aging Cell 11, 345\u2013349 (2012).","journal-title":"Aging Cell"},{"key":"1335_CR30","doi-asserted-by":"publisher","first-page":"1006","DOI":"10.1016\/j.cell.2008.03.038","volume":"133","author":"JC Acosta","year":"2008","unstructured":"Acosta, J. C. et al. Chemokine signaling via the CXCR2 receptor reinforces senescence. Cell 133, 1006\u20131018 (2008).","journal-title":"Cell"},{"key":"1335_CR31","doi-asserted-by":"publisher","first-page":"1019","DOI":"10.1016\/j.cell.2008.03.039","volume":"133","author":"T Kuilman","year":"2008","unstructured":"Kuilman, T. et al. Oncogene-induced senescence relayed by an interleukin-dependent inflammatory network. Cell 133, 1019\u20131031 (2008).","journal-title":"Cell"},{"key":"1335_CR32","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1101\/gad.349585.122","volume":"36","author":"K Yin","year":"2022","unstructured":"Yin, K. et al. Senescence-induced endothelial phenotypes underpin immune-mediated senescence surveillance. Genes Dev. 36, 533\u2013549 (2022).","journal-title":"Genes Dev."},{"key":"1335_CR33","first-page":"H2102","volume":"298","author":"GI Mun","year":"2010","unstructured":"Mun, G. I. & Boo, Y. C. Identification of CD44 as a senescence-induced cell adhesion gene responsible for the enhanced monocyte recruitment to senescent endothelial cells. Am. J. Physiol. 298, H2102\u20132111 (2010).","journal-title":"Am. J. Physiol."},{"key":"1335_CR34","doi-asserted-by":"publisher","first-page":"978","DOI":"10.1038\/ncb2784","volume":"15","author":"JC Acosta","year":"2013","unstructured":"Acosta, J. C. et al. A complex secretory program orchestrated by the inflammasome controls paracrine senescence. Nat. Cell Biol. 15, 978\u2013990 (2013).","journal-title":"Nat. Cell Biol."},{"key":"1335_CR35","doi-asserted-by":"publisher","first-page":"932","DOI":"10.18632\/aging.100520","volume":"4","author":"S Hubackova","year":"2012","unstructured":"Hubackova, S., Krejcikova, K., Bartek, J. & Hodny, Z. IL1- and TGF\u03b2-Nox4 signaling, oxidative stress and DNA damage response are shared features of replicative, oncogene-induced, and drug-induced paracrine \u2018bystander senescence\u2019. Aging 4, 932\u2013951 (2012).","journal-title":"Aging"},{"key":"1335_CR36","doi-asserted-by":"publisher","DOI":"10.59368\/agingbio.20230008","volume":"1","author":"SA Evans","year":"2023","unstructured":"Evans, S. A. et al. Single-cell transcriptomics reveals global markers of transcriptional diversity across different forms of cellular senescence. Aging Biol. 1, e20230008 (2023).","journal-title":"Aging Biol."},{"key":"1335_CR37","doi-asserted-by":"publisher","first-page":"1568","DOI":"10.1038\/s43587-025-00917-y","volume":"5","author":"Y Sogabe","year":"2025","unstructured":"Sogabe, Y. et al. Characterizing primary and secondary senescence in vivo. Nat. Aging 5, 1568\u20131588 (2025).","journal-title":"Nat. Aging"},{"key":"1335_CR38","doi-asserted-by":"publisher","first-page":"3827","DOI":"10.1083\/jcb.201904051","volume":"218","author":"CA Tonnessen-Murray","year":"2019","unstructured":"Tonnessen-Murray, C. A. et al. Chemotherapy-induced senescent cancer cells engulf other cells to enhance their survival. J. Cell Biol. 218, 3827\u20133844 (2019).","journal-title":"J. Cell Biol."},{"key":"1335_CR39","doi-asserted-by":"publisher","first-page":"3503","DOI":"10.1182\/blood-2008-08-173914","volume":"113","author":"A Soriani","year":"2009","unstructured":"Soriani, A. et al. ATM-ATR-dependent up-regulation of DNAM-1 and NKG2D ligands on multiple myeloma cells by therapeutic agents results in enhanced NK-cell susceptibility and is associated with a senescent phenotype. Blood 113, 3503\u20133511 (2009).","journal-title":"Blood"},{"key":"1335_CR40","doi-asserted-by":"publisher","first-page":"410","DOI":"10.1158\/2159-8290.CD-22-0523","volume":"13","author":"I Marin","year":"2023","unstructured":"Marin, I. et al. Cellular senescence is immunogenic and promotes antitumor immunity. Cancer Discov. 13, 410\u2013431 (2023). One of the first studies to characterize the immunogenicity of senescent cells and their potential as anticancer vaccines.","journal-title":"Cancer Discov."},{"key":"1335_CR41","doi-asserted-by":"publisher","DOI":"10.1101\/2022.11.17.515658","author":"D Gilioli","year":"2022","unstructured":"Gilioli, D. et al. Therapy-induced senescence upregulates antigen presentation machinery and triggers anti-tumor immunity in acute myeloid leukemia. Preprint at bioRxiv https:\/\/doi.org\/10.1101\/2022.11.17.515658 (2022).","journal-title":"Preprint at bioRxiv"},{"key":"1335_CR42","doi-asserted-by":"publisher","first-page":"729","DOI":"10.1038\/nrm2233","volume":"8","author":"J Campisi","year":"2007","unstructured":"Campisi, J. & d\u2019Adda di Fagagna, F. Cellular senescence: when bad things happen to good cells. Nat. Rev. Mol. Cell Biol. 8, 729\u2013740 (2007).","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"1335_CR43","doi-asserted-by":"publisher","first-page":"eabb3420","DOI":"10.1126\/science.abb3420","volume":"374","author":"I Sturmlechner","year":"2021","unstructured":"Sturmlechner, I. et al. p21 produces a bioactive secretome that places stressed cells under immunosurveillance. Science 374, eabb3420 (2021). One of only a few studies exploring the temporal dynamics of immune surveillance of p21CIP1-expressing senescent cells.","journal-title":"Science"},{"key":"1335_CR44","doi-asserted-by":"publisher","first-page":"101275","DOI":"10.1016\/j.smim.2019.04.003","volume":"40","author":"L Prata","year":"2018","unstructured":"Prata, L., Ovsyannikova, I. G., Tchkonia, T. & Kirkland, J. L. Senescent cell clearance by the immune system: emerging therapeutic opportunities. Semin. Immunol. 40, 101275 (2018).","journal-title":"Semin. Immunol."},{"key":"1335_CR45","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1038\/nature10599","volume":"479","author":"TW Kang","year":"2011","unstructured":"Kang, T. W. et al. Senescence surveillance of pre-malignant hepatocytes limits liver cancer development. Nature 479, 547\u2013551 (2011). An in-depth study that describes how premalignant senescent cells promote their own targeted immune surveillance.","journal-title":"Nature"},{"key":"1335_CR46","doi-asserted-by":"publisher","first-page":"2197","DOI":"10.1016\/j.jid.2017.05.030","volume":"137","author":"J van Tuyn","year":"2017","unstructured":"van Tuyn, J. et al. Oncogene-expressing senescent melanocytes up-regulate MHC class II, a candidate melanoma suppressor function. J. Invest. Dermatol. 137, 2197\u20132207 (2017).","journal-title":"J. Invest. Dermatol."},{"key":"1335_CR47","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/j.celrep.2014.08.044","volume":"9","author":"A Toso","year":"2014","unstructured":"Toso, A. et al. Enhancing chemotherapy efficacy in Pten-deficient prostate tumors by activating the senescence-associated antitumor immunity. Cell Rep. 9, 75\u201389 (2014).","journal-title":"Cell Rep."},{"key":"1335_CR48","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1038\/nature13638","volume":"515","author":"D Di Mitri","year":"2014","unstructured":"Di Mitri, D. et al. Tumour-infiltrating Gr-1+ myeloid cells antagonize senescence in cancer. Nature 515, 134\u2013137 (2014).","journal-title":"Nature"},{"key":"1335_CR49","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1016\/j.ccell.2016.09.003","volume":"30","author":"T Eggert","year":"2016","unstructured":"Eggert, T. et al. Distinct functions of senescence-associated immune responses in liver tumor surveillance and tumor progression. Cancer Cell 30, 533\u2013547 (2016).","journal-title":"Cancer Cell"},{"key":"1335_CR50","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1007\/s00262-025-04060-w","volume":"74","author":"P Engels","year":"2025","unstructured":"Engels, P. et al. Actionable heterogeneity of hepatocellular carcinoma therapy-induced senescence. Cancer Immunol. Immunother. 74, 207 (2025).","journal-title":"Cancer Immunol. Immunother."},{"key":"1335_CR51","doi-asserted-by":"publisher","DOI":"10.1186\/s12935-024-03351-z","volume":"24","author":"X Cai","year":"2024","unstructured":"Cai, X. et al. CDK4\/6 inhibition enhances T-cell immunotherapy on hepatocellular carcinoma cells by rejuvenating immunogenicity. Cancer Cell Int. 24, 215 (2024).","journal-title":"Cancer Cell Int."},{"key":"1335_CR52","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1038\/s41586-019-1607-3","volume":"574","author":"C Wang","year":"2019","unstructured":"Wang, C. et al. Inducing and exploiting vulnerabilities for the treatment of liver cancer. Nature 574, 268\u2013272 (2019).","journal-title":"Nature"},{"key":"1335_CR53","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1002\/hep.32285","volume":"75","author":"SL Friedman","year":"2022","unstructured":"Friedman, S. L. & Pinzani, M. Hepatic fibrosis 2022: unmet needs and a blueprint for the future. Hepatology 75, 473\u2013488 (2022).","journal-title":"Hepatology"},{"key":"1335_CR54","doi-asserted-by":"publisher","first-page":"1971","DOI":"10.1038\/onc.2012.206","volume":"32","author":"A Sagiv","year":"2013","unstructured":"Sagiv, A. et al. Granule exocytosis mediates immune surveillance of senescent cells. Oncogene 32, 1971\u20131977 (2013).","journal-title":"Oncogene"},{"key":"1335_CR55","doi-asserted-by":"publisher","first-page":"328","DOI":"10.18632\/aging.100897","volume":"8","author":"A Sagiv","year":"2016","unstructured":"Sagiv, A. et al. NKG2D ligands mediate immunosurveillance of senescent cells. Aging 8, 328\u2013344 (2016).","journal-title":"Aging"},{"key":"1335_CR56","doi-asserted-by":"publisher","first-page":"1416","DOI":"10.1126\/science.aas9090","volume":"362","author":"M Ruscetti","year":"2018","unstructured":"Ruscetti, M. et al. NK cell-mediated cytotoxicity contributes to tumor control by a cytostatic drug combination. Science 362, 1416\u20131422 (2018).","journal-title":"Science"},{"key":"1335_CR57","doi-asserted-by":"publisher","first-page":"eadd1951","DOI":"10.1126\/scitranslmed.add1951","volume":"15","author":"D Yang","year":"2023","unstructured":"Yang, D. et al. NKG2D-CAR T cells eliminate senescent cells in aged mice and nonhuman primates. Sci. Transl. Med. 15, eadd1951 (2023).","journal-title":"Sci. Transl. Med."},{"key":"1335_CR58","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1038\/s41586-022-05388-4","volume":"611","author":"TW Wang","year":"2022","unstructured":"Wang, T. W. et al. Blocking PD-L1-PD-1 improves senescence surveillance and ageing phenotypes. Nature 611, 358\u2013364 (2022). One of the first studies to provide evidence that immune checkpoint blockade can enhance the immune surveillance of senescent cells.","journal-title":"Nature"},{"key":"1335_CR59","doi-asserted-by":"publisher","first-page":"E1668","DOI":"10.1073\/pnas.1614661114","volume":"114","author":"D Frescas","year":"2017","unstructured":"Frescas, D. et al. Senescent cells expose and secrete an oxidized form of membrane-bound vimentin as revealed by a natural polyreactive antibody. Proc. Natl Acad. Sci. USA 114, E1668\u2013E1677 (2017).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"1335_CR60","doi-asserted-by":"publisher","first-page":"938","DOI":"10.1016\/j.medj.2021.04.014","volume":"2","author":"S Arora","year":"2021","unstructured":"Arora, S. et al. Invariant natural killer T cells coordinate removal of senescent cells. Med 2, 938\u2013950 (2021).","journal-title":"Med"},{"key":"1335_CR61","doi-asserted-by":"publisher","DOI":"10.1038\/s41389-019-0133-3","volume":"8","author":"KL Stokes","year":"2019","unstructured":"Stokes, K. L. et al. Natural killer cells limit the clearance of senescent lung adenocarcinoma cells. Oncogenesis 8, 24 (2019).","journal-title":"Oncogenesis"},{"key":"1335_CR62","doi-asserted-by":"publisher","first-page":"2057","DOI":"10.1084\/jem.20130783","volume":"210","author":"A Iannello","year":"2013","unstructured":"Iannello, A., Thompson, T. W., Ardolino, M., Lowe, S. W. & Raulet, D. H. p53-dependent chemokine production by senescent tumor cells supports NKG2D-dependent tumor elimination by natural killer cells. J. Exp. Med. 210, 2057\u20132069 (2013).","journal-title":"J. Exp. Med."},{"key":"1335_CR63","doi-asserted-by":"publisher","first-page":"2200","DOI":"10.1016\/j.cmet.2023.10.014","volume":"35","author":"H Lee","year":"2023","unstructured":"Lee, H. et al. Stress-induced \u03b2 cell early senescence confers protection against type 1 diabetes. Cell Metab. 35, 2200\u20132215 e2209 (2023).","journal-title":"Cell Metab."},{"key":"1335_CR64","doi-asserted-by":"publisher","first-page":"642","DOI":"10.1038\/436642a","volume":"436","author":"M Collado","year":"2005","unstructured":"Collado, M. et al. Tumour biology: senescence in premalignant tumours. Nature 436, 642 (2005).","journal-title":"Nature"},{"key":"1335_CR65","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1038\/s41586-020-2403-9","volume":"583","author":"C Amor","year":"2020","unstructured":"Amor, C. et al. Senolytic CAR T cells reverse senescence-associated pathologies. Nature 583, 127\u2013132 (2020). One of the first studies to report the development of senolytic CAR T cells.","journal-title":"Nature"},{"key":"1335_CR66","doi-asserted-by":"publisher","first-page":"642","DOI":"10.1038\/s41586-020-03147-x","volume":"590","author":"D Alonso-Curbelo","year":"2021","unstructured":"Alonso-Curbelo, D. et al. A gene-environment-induced epigenetic program initiates tumorigenesis. Nature 590, 642\u2013648 (2021).","journal-title":"Nature"},{"key":"1335_CR67","doi-asserted-by":"publisher","first-page":"791","DOI":"10.1101\/gad.259341.115","volume":"29","author":"A Biran","year":"2015","unstructured":"Biran, A. et al. Senescent cells communicate via intercellular protein transfer. Genes Dev. 29, 791\u2013802 (2015).","journal-title":"Genes Dev."},{"key":"1335_CR68","doi-asserted-by":"publisher","first-page":"448","DOI":"10.1038\/s43018-023-00712-x","volume":"5","author":"S Chaib","year":"2024","unstructured":"Chaib, S. et al. The efficacy of chemotherapy is limited by intratumoral senescent cells expressing PD-L2. Nat. Cancer 5, 448\u2013462 (2024).","journal-title":"Nat. Cancer"},{"key":"1335_CR69","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1038\/nature11824","volume":"494","author":"H Braum\u00fcller","year":"2013","unstructured":"Braum\u00fcller, H. et al. T-helper-1-cell cytokines drive cancer into senescence. Nature 494, 361\u2013365 (2013).","journal-title":"Nature"},{"key":"1335_CR70","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-14987-6","volume":"11","author":"E Brenner","year":"2020","unstructured":"Brenner, E. et al. Cancer immune control needs senescence induction by interferon-dependent cell cycle regulator pathways in tumours. Nat. Commun. 11, 1335 (2020).","journal-title":"Nat. Commun."},{"key":"1335_CR71","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1016\/j.ccr.2010.10.002","volume":"18","author":"K Rakhra","year":"2010","unstructured":"Rakhra, K. et al. CD4(+) T cells contribute to the remodeling of the microenvironment required for sustained tumor regression upon oncogene inactivation. Cancer Cell 18, 485\u2013498 (2010).","journal-title":"Cancer Cell"},{"key":"1335_CR72","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms11762","volume":"7","author":"MK Ruhland","year":"2016","unstructured":"Ruhland, M. K. et al. Stromal senescence establishes an immunosuppressive microenvironment that drives tumorigenesis. Nat. Commun. 7, 11762 (2016).","journal-title":"Nat. Commun."},{"key":"1335_CR73","doi-asserted-by":"publisher","first-page":"1417","DOI":"10.1016\/j.cell.2023.02.033","volume":"186","author":"T Hasegawa","year":"2023","unstructured":"Hasegawa, T. et al. Cytotoxic CD4+ T cells eliminate senescent cells by targeting cytomegalovirus antigen. Cell 186, 1417\u20131431 e1420 (2023). This study provides evidence that naturally occurring senescent cells in human aged skin are surveilled by the immune system.","journal-title":"Cell"},{"key":"1335_CR74","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1158\/0008-5472.CAN-24-0529","volume":"85","author":"V Ramponi","year":"2025","unstructured":"Ramponi, V. et al. H4K20me3-mediated repression of inflammatory genes is a characteristic and targetable vulnerability of persister cancer cells. Cancer Res. 85, 32\u201351 (2025).","journal-title":"Cancer Res."},{"key":"1335_CR75","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1038\/s43587-025-01058-y","volume":"6","author":"A Chiche","year":"2026","unstructured":"Chiche, A. et al. Induction of senescence during postpartum mammary gland involution supports tissue remodeling and promotes postpartum tumorigenesis. Nat. Aging 6, 541\u2013559 (2026).","journal-title":"Nat. Aging"},{"key":"1335_CR76","doi-asserted-by":"publisher","first-page":"eadp7022","DOI":"10.1126\/sciadv.adp7022","volume":"10","author":"Z Wang","year":"2024","unstructured":"Wang, Z. et al. Reprogramming cellular senescence in the tumor microenvironment augments cancer immunotherapy through multifunctional nanocrystals. Sci. Adv. 10, eadp7022 (2024).","journal-title":"Sci. Adv."},{"key":"1335_CR77","doi-asserted-by":"publisher","first-page":"101148","DOI":"10.1016\/j.neo.2025.101148","volume":"63","author":"MV Saatloo","year":"2025","unstructured":"Saatloo, M. V., Delisi, D., Eskandari, N., Krieg, C. & Gentile, S. Kv11.1-dependent senescence activates a lethal immune response via tumor necrosis factor alpha. Neoplasia 63, 101148 (2025).","journal-title":"Neoplasia"},{"key":"1335_CR78","doi-asserted-by":"publisher","first-page":"eadx2988","DOI":"10.1126\/sciadv.adx2988","volume":"12","author":"M Lalinde-Guti\u00e9rrez","year":"2026","unstructured":"Lalinde-Guti\u00e9rrez, M. et al. Immunosuppressive macrophages determine the effect of cellular senescence on tumor progression. Sci. Adv. 12, eadx2988 (2026).","journal-title":"Sci. Adv."},{"key":"1335_CR79","doi-asserted-by":"publisher","first-page":"2344","DOI":"10.1210\/en.2016-1886","volume":"158","author":"M Egashira","year":"2017","unstructured":"Egashira, M. et al. F4\/80+ macrophages contribute to clearance of senescent cells in the mouse postpartum uterus. Endocrinology 158, 2344\u20132353 (2017).","journal-title":"Endocrinology"},{"key":"1335_CR80","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.31274","volume":"6","author":"PJ Brighton","year":"2017","unstructured":"Brighton, P. J. et al. Clearance of senescent decidual cells by uterine natural killer cells in cycling human endometrium. eLife 6, e31274 (2017).","journal-title":"eLife"},{"key":"1335_CR81","doi-asserted-by":"publisher","first-page":"1119","DOI":"10.1016\/j.cell.2013.10.041","volume":"155","author":"M Storer","year":"2013","unstructured":"Storer, M. et al. Senescence is a developmental mechanism that contributes to embryonic growth and patterning. Cell 155, 1119\u20131130 (2013).","journal-title":"Cell"},{"key":"1335_CR82","doi-asserted-by":"publisher","DOI":"10.1111\/acel.70180","volume":"24","author":"Z Li","year":"2025","unstructured":"Li, Z. et al. Single-cell sequencing reveals that CD4+ T cells eliminate senescent prostate epithelium to delay progression of benign prostatic hyperplasia. Aging Cell 24, e70180 (2025).","journal-title":"Aging Cell"},{"key":"1335_CR83","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1158\/2159-8290.CD-25-1212","volume":"16","author":"L Zhou","year":"2026","unstructured":"Zhou, L. et al. p21-positive senescent stromal cells promote prostate cancer immune suppression and progression that can be reversed by senolytic therapy. Cancer Discov. 16, 571\u2013591 (2026).","journal-title":"Cancer Discov."},{"key":"1335_CR84","doi-asserted-by":"publisher","first-page":"2017","DOI":"10.1128\/MCB.00090-14","volume":"34","author":"AJ Garcia","year":"2014","unstructured":"Garcia, A. J. et al. Pten null prostate epithelium promotes localized myeloid-derived suppressor cell expansion and immune suppression during tumor initiation and progression. Mol. Cell Biol. 34, 2017\u20132028 (2014).","journal-title":"Mol. Cell Biol."},{"key":"1335_CR85","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1016\/j.ccell.2024.02.004","volume":"42","author":"M Colucci","year":"2024","unstructured":"Colucci, M. et al. Retinoic acid receptor activation reprograms senescence response and enhances anti-tumor activity of natural killer cells. Cancer Cell 42, 646\u2013661.e649 (2024).","journal-title":"Cancer Cell"},{"key":"1335_CR86","doi-asserted-by":"publisher","first-page":"eadn2811","DOI":"10.1126\/sciadv.adn2811","volume":"11","author":"V Reen","year":"2025","unstructured":"Reen, V. et al. SMARCA4 regulates the NK-mediated killing of senescent cells. Sci. Adv. 11, eadn2811 (2025).","journal-title":"Sci. Adv."},{"key":"1335_CR87","doi-asserted-by":"publisher","first-page":"1802","DOI":"10.3390\/ijms21051802","volume":"21","author":"A Ratushnyy","year":"2020","unstructured":"Ratushnyy, A., Ezdakova, M. & Buravkova, L. Secretome of senescent adipose-derived mesenchymal stem cells negatively regulates angiogenesis. Int. J. Mol. Sci. 21, 1802 (2020).","journal-title":"Int. J. Mol. Sci."},{"key":"1335_CR88","doi-asserted-by":"publisher","first-page":"811","DOI":"10.1016\/j.immuni.2025.03.005","volume":"58","author":"P Lai","year":"2025","unstructured":"Lai, P. et al. Mitochondrial DNA released by senescent tumor cells enhances PMN-MDSC-driven immunosuppression through the cGAS-STING pathway. Immunity 58, 811\u2013825.e817 (2025).","journal-title":"Immunity"},{"key":"1335_CR89","doi-asserted-by":"publisher","first-page":"1656","DOI":"10.1038\/s43018-025-01007-z","volume":"6","author":"G Petroni","year":"2025","unstructured":"Petroni, G. et al. IL-17A-secreting \u03b3\u03b4 T cells promote resistance to CDK4\/CDK6 inhibitors in HR+HER2\u2212 breast cancer via CX3CR1+ macrophages. Nat. Cancer 6, 1656\u20131675 (2025).","journal-title":"Nat. Cancer"},{"key":"1335_CR90","doi-asserted-by":"publisher","first-page":"1302","DOI":"10.1158\/2159-8290.CD-23-0426","volume":"14","author":"J Ye","year":"2024","unstructured":"Ye, J. et al. Senescent CAFs mediate immunosuppression and drive breast cancer progression. Cancer Discov. 14, 1302\u20131323 (2024).","journal-title":"Cancer Discov."},{"key":"1335_CR91","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-024-50441-7","volume":"15","author":"B Assouline","year":"2024","unstructured":"Assouline, B. et al. Senescent cancer-associated fibroblasts in pancreatic adenocarcinoma restrict CD8+ T cell activation and limit responsiveness to immunotherapy in mice. Nat. Commun. 15, 6162 (2024).","journal-title":"Nat. Commun."},{"key":"1335_CR92","doi-asserted-by":"publisher","first-page":"1242","DOI":"10.1016\/j.ccell.2023.05.004","volume":"41","author":"S Haston","year":"2023","unstructured":"Haston, S. et al. Clearance of senescent macrophages ameliorates tumorigenesis in KRAS-driven lung cancer. Cancer Cell 41, 1242\u20131260.e1246 (2023).","journal-title":"Cancer Cell"},{"key":"1335_CR93","doi-asserted-by":"publisher","first-page":"1261","DOI":"10.1016\/j.ccell.2023.05.006","volume":"41","author":"LI Prieto","year":"2023","unstructured":"Prieto, L. I. et al. Senescent alveolar macrophages promote early-stage lung tumorigenesis. Cancer Cell 41, 1261\u20131275.e1266 (2023).","journal-title":"Cancer Cell"},{"key":"1335_CR94","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2412818122","volume":"122","author":"Y Zhang","year":"2025","unstructured":"Zhang, Y. et al. Signaling networks in cancer stromal senescent cells establish malignant microenvironment. Proc. Natl Acad. Sci. USA 122, e2412818122 (2025).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"1335_CR95","doi-asserted-by":"publisher","DOI":"10.1083\/jcb.202207097","volume":"222","author":"D Schloesser","year":"2023","unstructured":"Schloesser, D. et al. Senescent cells suppress macrophage-mediated corpse removal via upregulation of the CD47-QPCT\/L axis. J. Cell Biol. 222, e202207097 (2023).","journal-title":"J. Cell Biol."},{"key":"1335_CR96","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-019-10335-5","volume":"10","author":"BI Pereira","year":"2019","unstructured":"Pereira, B. I. et al. Senescent cells evade immune clearance via HLA-E-mediated NK and CD8+ T cell inhibition. Nat. Commun. 10, 2387 (2019).","journal-title":"Nat. Commun."},{"key":"1335_CR97","doi-asserted-by":"publisher","first-page":"2013","DOI":"10.1007\/s11357-025-01903-3","volume":"48","author":"C Fissoun","year":"2026","unstructured":"Fissoun, C. et al. The ganglioside GD3 and its synthase (ST8SIA1) as novel senescence markers associated with osteoarthritis. Geroscience 48, 2013\u20132027 (2026).","journal-title":"Geroscience"},{"key":"1335_CR98","first-page":"L849","volume":"324","author":"L Yang","year":"2023","unstructured":"Yang, L. et al. IL-8 concurrently promotes idiopathic pulmonary fibrosis mesenchymal progenitor cell senescence and PD-L1 expression enabling escape from immune cell surveillance. Am. J. Physiol. 324, L849\u2013L862 (2023).","journal-title":"Am. J. Physiol."},{"key":"1335_CR99","doi-asserted-by":"publisher","DOI":"10.1111\/acel.70141","volume":"24","author":"G Meca-Laguna","year":"2025","unstructured":"Meca-Laguna, G. et al. Cell-surface LAMP1 is a senescence marker in aging and idiopathic pulmonary fibrosis. Aging Cell 24, e70141 (2025).","journal-title":"Aging Cell"},{"key":"1335_CR100","doi-asserted-by":"publisher","first-page":"1713","DOI":"10.1002\/art.43244","volume":"77","author":"S Yamamoto","year":"2025","unstructured":"Yamamoto, S. et al. Orchestration of skin pathology in cutaneous lupus erythematosus by HLA class I down-regulated senescent epidermal basal cells. Arthritis Rheumatol. 77, 1713\u20131725 (2025).","journal-title":"Arthritis Rheumatol."},{"key":"1335_CR101","doi-asserted-by":"publisher","first-page":"102694","DOI":"10.1016\/j.arr.2025.102694","volume":"106","author":"A Salminen","year":"2025","unstructured":"Salminen, A. Cooperation between inhibitory immune checkpoints of senescent cells with immunosuppressive network to promote immunosenescence and the aging process. Ageing Res. Rev. 106, 102694 (2025).","journal-title":"Ageing Res. Rev."},{"key":"1335_CR102","doi-asserted-by":"publisher","DOI":"10.1128\/mcb.00171-22","volume":"42","author":"A Onorati","year":"2022","unstructured":"Onorati, A. et al. Upregulation of PD-L1 in senescence and aging. Mol. Cell Biol. 42, e0017122 (2022).","journal-title":"Mol. Cell Biol."},{"key":"1335_CR103","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-024-54132-1","volume":"16","author":"HJ Hwang","year":"2025","unstructured":"Hwang, H. J. et al. Therapy-induced senescent cancer cells contribute to cancer progression by promoting ribophorin 1-dependent PD-L1 upregulation. Nat. Commun. 16, 353 (2025).","journal-title":"Nat. Commun."},{"key":"1335_CR104","doi-asserted-by":"publisher","first-page":"1336","DOI":"10.1038\/s41556-024-01465-0","volume":"26","author":"J Majewska","year":"2024","unstructured":"Majewska, J. et al. p16-dependent increase of PD-L1 stability regulates immunosurveillance of senescent cells. Nat. Cell Biol. 26, 1336\u20131345 (2024).","journal-title":"Nat. Cell Biol."},{"key":"1335_CR105","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jiag133","author":"R Ayala-Su\u00e1rez","year":"2026","unstructured":"Ayala-Su\u00e1rez, R. et al. Changes in cellular senescence biomarkers across individuals at different stages of HIV infection before and after a year on antiretroviral therapy. J. Infect. Dis. https:\/\/doi.org\/10.1093\/infdis\/jiag133 (2026).","journal-title":"J. Infect. Dis."},{"key":"1335_CR106","doi-asserted-by":"publisher","first-page":"1707510","DOI":"10.3389\/fimmu.2025.1707510","volume":"16","author":"C Pita-Mart\u00ednez","year":"2025","unstructured":"Pita-Mart\u00ednez, C. et al. Immune and senescence profiles associated with non-AIDS-defining cancer risk in people with HIV: a case-cohort study. Front. Immunol. 16, 1707510 (2025).","journal-title":"Front. Immunol."},{"key":"1335_CR107","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-025-65025-2","volume":"16","author":"CO Ontiveros","year":"2025","unstructured":"Ontiveros, C. O. et al. Anti-PD-L2 immunotherapy is efficacious against melanoma in aged hosts through IL-17 and IFN\u03b3 signalling. Nat. Commun. 16, 10176 (2025).","journal-title":"Nat. Commun."},{"key":"1335_CR108","doi-asserted-by":"publisher","DOI":"10.1172\/JCI181775","volume":"135","author":"S Yadav","year":"2025","unstructured":"Yadav, S. et al. Reactivation of CTLA4-expressing T cells accelerates resolution of lung fibrosis in a humanized mouse model. J. Clin. Invest. 135, e181775 (2025).","journal-title":"J. Clin. Invest."},{"key":"1335_CR109","doi-asserted-by":"publisher","first-page":"1513","DOI":"10.1038\/s43018-022-00466-y","volume":"3","author":"A Shahbandi","year":"2022","unstructured":"Shahbandi, A. et al. Breast cancer cells survive chemotherapy by activating targetable immune-modulatory programs characterized by PD-L1 or CD80. Nat. Cancer 3, 1513\u20131533 (2022).","journal-title":"Nat. Cancer"},{"key":"1335_CR110","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1038\/nature10600","volume":"479","author":"DJ Baker","year":"2011","unstructured":"Baker, D. J. et al. Clearance of p16Ink4a-positive senescent cells delays ageing-associated disorders. Nature 479, 232\u2013236 (2011).","journal-title":"Nature"},{"key":"1335_CR111","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1038\/nature16932","volume":"530","author":"DJ Baker","year":"2016","unstructured":"Baker, D. J. et al. Naturally occurring p16(Ink4a)-positive cells shorten healthy lifespan. Nature 530, 184\u2013189 (2016).","journal-title":"Nature"},{"key":"1335_CR112","doi-asserted-by":"publisher","first-page":"578","DOI":"10.1038\/s41586-018-0543-y","volume":"562","author":"TJ Bussian","year":"2018","unstructured":"Bussian, T. J. et al. Clearance of senescent glial cells prevents tau-dependent pathology and cognitive decline. Nature 562, 578\u2013582 (2018).","journal-title":"Nature"},{"key":"1335_CR113","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms15691","volume":"8","author":"M Ogrodnik","year":"2017","unstructured":"Ogrodnik, M. et al. Cellular senescence drives age-dependent hepatic steatosis. Nat. Commun. 8, 15691 (2017).","journal-title":"Nat. Commun."},{"key":"1335_CR114","doi-asserted-by":"publisher","first-page":"1072","DOI":"10.1038\/nm.4385","volume":"23","author":"JN Farr","year":"2017","unstructured":"Farr, J. N. et al. Targeting cellular senescence prevents age-related bone loss in mice. Nat. Med. 23, 1072\u20131079 (2017).","journal-title":"Nat. Med."},{"key":"1335_CR115","doi-asserted-by":"publisher","first-page":"1246","DOI":"10.1038\/s41591-018-0092-9","volume":"24","author":"M Xu","year":"2018","unstructured":"Xu, M. et al. Senolytics improve physical function and increase lifespan in old age. Nat. Med. 24, 1246\u20131256 (2018).","journal-title":"Nat. Med."},{"key":"1335_CR116","doi-asserted-by":"publisher","first-page":"926","DOI":"10.1038\/s43587-024-00642-y","volume":"4","author":"G Katsuumi","year":"2024","unstructured":"Katsuumi, G. et al. SGLT2 inhibition eliminates senescent cells and alleviates pathological aging. Nat. Aging 4, 926\u2013938 (2024).","journal-title":"Nat. Aging"},{"key":"1335_CR117","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-16347-w","volume":"11","author":"S Yoshida","year":"2020","unstructured":"Yoshida, S. et al. The CD153 vaccine is a senotherapeutic option for preventing the accumulation of senescent T cells in mice. Nat. Commun. 11, 2482 (2020).","journal-title":"Nat. Commun."},{"key":"1335_CR118","doi-asserted-by":"publisher","first-page":"1117","DOI":"10.1038\/s43587-021-00151-2","volume":"1","author":"M Suda","year":"2021","unstructured":"Suda, M. et al. Senolytic vaccination improves normal and pathological age-related phenotypes and increases lifespan in progeroid mice. Nat. Aging 1, 1117\u20131126 (2021).","journal-title":"Nat. Aging"},{"key":"1335_CR119","doi-asserted-by":"publisher","first-page":"1046","DOI":"10.1038\/mt.2012.19","volume":"20","author":"Y Meng","year":"2012","unstructured":"Meng, Y. et al. Radiation-inducible immunotherapy for cancer: senescent tumor cells as a cancer vaccine. Mol. Ther. 20, 1046\u20131055 (2012).","journal-title":"Mol. Ther."},{"key":"1335_CR120","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202400630","volume":"11","author":"C Yang","year":"2024","unstructured":"Yang, C. et al. Leveraging senescent cancer cell membrane to potentiate cancer immunotherapy through biomimetic nanovaccine. Adv. Sci. 11, e2400630 (2024).","journal-title":"Adv. Sci."},{"key":"1335_CR121","doi-asserted-by":"publisher","first-page":"913","DOI":"10.1016\/j.jhep.2024.01.034","volume":"80","author":"H Dai","year":"2024","unstructured":"Dai, H. et al. Chimeric antigen receptor-modified macrophages ameliorate liver fibrosis in preclinical models. J. Hepatol. 80, 913\u2013927 (2024).","journal-title":"J. Hepatol."},{"key":"1335_CR122","doi-asserted-by":"publisher","first-page":"102209","DOI":"10.1016\/j.xcrm.2025.102209","volume":"6","author":"Z Zhang","year":"2025","unstructured":"Zhang, Z. et al. Cardiolipin-mimic lipid nanoparticles without antibody modification delivered senolytic in vivo CAR-T therapy for inflamm-aging. Cell Rep. Med. 6, 102209 (2025).","journal-title":"Cell Rep. Med."},{"key":"1335_CR123","doi-asserted-by":"publisher","first-page":"336","DOI":"10.1038\/s43587-023-00560-5","volume":"4","author":"C Amor","year":"2024","unstructured":"Amor, C. et al. Prophylactic and long-lasting efficacy of senolytic CAR T cells against age-related metabolic dysfunction. Nat. Aging 4, 336\u2013349 (2024).","journal-title":"Nat. Aging"},{"key":"1335_CR124","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1038\/s43587-025-01022-w","volume":"6","author":"O Eskiocak","year":"2026","unstructured":"Eskiocak, O. et al. Anti-uPAR CAR T cells reverse and prevent aging-associated defects in intestinal regeneration and fitness. Nat. Aging 6, 108\u2013126 (2026).","journal-title":"Nat. Aging"},{"key":"1335_CR125","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1021\/acschembio.1c00808","volume":"17","author":"NJ Rettko","year":"2022","unstructured":"Rettko, N. J., Campisi, J. & Wells, J. A. Engineering antibodies targeting p16 MHC-peptide complexes. ACS Chem. Biol. 17, 545\u2013555 (2022).","journal-title":"ACS Chem. Biol."},{"key":"1335_CR126","doi-asserted-by":"publisher","first-page":"eadj6251","DOI":"10.1126\/sciadv.adj6251","volume":"10","author":"L Lu","year":"2024","unstructured":"Lu, L., Xie, M., Yang, B., Zhao, W. B. & Cao, J. Enhancing the safety of CAR-T cell therapy: synthetic genetic switch for spatiotemporal control. Sci. Adv. 10, eadj6251 (2024).","journal-title":"Sci. Adv."},{"key":"1335_CR127","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-021-99852-2","volume":"11","author":"M Poblocka","year":"2021","unstructured":"Poblocka, M. et al. Targeted clearance of senescent cells using an antibody-drug conjugate against a specific membrane marker. Sci. Rep. 11, 20358 (2021).","journal-title":"Sci. Rep."},{"key":"1335_CR128","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1089\/rej.2022.0056","volume":"26","author":"K Takaya","year":"2023","unstructured":"Takaya, K., Asou, T. & Kishi, K. Identification of apolipoprotein D as a dermal fibroblast marker of human aging for development of skin rejuvenation therapy. Rejuvenation Res. 26, 42\u201350 (2023).","journal-title":"Rejuvenation Res."},{"key":"1335_CR129","doi-asserted-by":"publisher","first-page":"123461","DOI":"10.1016\/j.biomaterials.2025.123461","volume":"324","author":"B Escriche-Navarro","year":"2026","unstructured":"Escriche-Navarro, B. et al. Targeting the senescent surfaceome through DPP4 antibody-functionalized nanoparticles. An application to cancer therapy. Biomaterials 324, 123461 (2026).","journal-title":"Biomaterials"},{"key":"1335_CR130","doi-asserted-by":"publisher","first-page":"1529","DOI":"10.1101\/gad.302570.117","volume":"31","author":"KM Kim","year":"2017","unstructured":"Kim, K. M. et al. Identification of senescent cell surface targetable protein DPP4. Genes Dev. 31, 1529\u20131534 (2017).","journal-title":"Genes Dev."},{"key":"1335_CR131","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1038\/s43587-024-00750-9","volume":"5","author":"X Ming","year":"2025","unstructured":"Ming, X. et al. A chimeric peptide promotes immune surveillance of senescent cells in injury, fibrosis, tumorigenesis and aging. Nat. Aging 5, 28\u201347 (2025).","journal-title":"Nat. Aging"},{"key":"1335_CR132","doi-asserted-by":"publisher","first-page":"1562","DOI":"10.1038\/s43587-024-00694-0","volume":"4","author":"J Hou","year":"2024","unstructured":"Hou, J. et al. Aged bone marrow macrophages drive systemic aging and age-related dysfunction via extracellular vesicle-mediated induction of paracrine senescence. Nat. Aging 4, 1562\u20131581 (2024).","journal-title":"Nat. Aging"},{"key":"1335_CR133","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1038\/s41586-021-03547-7","volume":"594","author":"MJ Yousefzadeh","year":"2021","unstructured":"Yousefzadeh, M. J. et al. An aged immune system drives senescence and ageing of solid organs. Nature 594, 100\u2013105 (2021).","journal-title":"Nature"},{"key":"1335_CR134","doi-asserted-by":"publisher","first-page":"1920","DOI":"10.1002\/jbmr.2892","volume":"31","author":"JN Farr","year":"2016","unstructured":"Farr, J. N. et al. Identification of senescent cells in the bone microenvironment. J. Bone Miner. Res. 31, 1920\u20131929 (2016).","journal-title":"J. Bone Miner. Res."},{"key":"1335_CR135","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-022-32552-1","volume":"13","author":"D Saul","year":"2022","unstructured":"Saul, D. et al. A new gene set identifies senescent cells and predicts senescence-associated pathways across tissues. Nat. Commun. 13, 4827 (2022).","journal-title":"Nat. Commun."},{"key":"1335_CR136","doi-asserted-by":"publisher","first-page":"4150","DOI":"10.1016\/j.cell.2024.05.059","volume":"187","author":"M Ogrodnik","year":"2024","unstructured":"Ogrodnik, M. et al. Guidelines for minimal information on cellular senescence experimentation in vivo. Cell 187, 4150\u20134175 (2024).","journal-title":"Cell"},{"key":"1335_CR137","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1038\/nrc3960","volume":"15","author":"NE Sharpless","year":"2015","unstructured":"Sharpless, N. E. & Sherr, C. J. Forging a signature of in vivo senescence. Nat. Rev. Cancer 15, 397\u2013408 (2015).","journal-title":"Nat. Rev. Cancer"},{"key":"1335_CR138","doi-asserted-by":"publisher","first-page":"9363","DOI":"10.1073\/pnas.92.20.9363","volume":"92","author":"GP Dimri","year":"1995","unstructured":"Dimri, G. P. et al. A biomarker that identifies senescent human cells in culture and in aging skin in vivo. Proc. Natl Acad. Sci. USA 92, 9363\u20139367 (1995).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"1335_CR139","doi-asserted-by":"publisher","first-page":"612","DOI":"10.1158\/2159-8290.CD-16-0217","volume":"6","author":"N Tasdemir","year":"2016","unstructured":"Tasdemir, N. et al. BRD4 connects enhancer remodeling to senescence immune surveillance. Cancer Discov. 6, 612\u2013629 (2016).","journal-title":"Cancer Discov."},{"key":"1335_CR140","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1038\/s41556-021-00656-3","volume":"23","author":"P Liu","year":"2021","unstructured":"Liu, P. et al. m(6)A-independent genome-wide METTL3 and METTL14 redistribution drives the senescence-associated secretory phenotype. Nat. Cell Biol. 23, 355\u2013365 (2021).","journal-title":"Nat. Cell Biol."},{"key":"1335_CR141","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1111\/febs.15570","volume":"288","author":"E Gonz\u00e1lez-Gualda","year":"2021","unstructured":"Gonz\u00e1lez-Gualda, E., Baker, A. G., Fruk, L. & Munoz-Espin, D. A guide to assessing cellular senescence in vitro and in vivo. FEBS J. 288, 56\u201380 (2021).","journal-title":"FEBS J."},{"key":"1335_CR142","doi-asserted-by":"publisher","first-page":"pgad400","DOI":"10.1093\/pnasnexus\/pgad400","volume":"2","author":"NJ Rettko","year":"2023","unstructured":"Rettko, N. J., Kirkemo, L. L. & Wells, J. A. Secreted HLA-Fc fusion profiles immunopeptidome in hypoxic PDAC and cellular senescence. PNAS Nexus 2, pgad400 (2023).","journal-title":"PNAS Nexus"},{"key":"1335_CR143","doi-asserted-by":"publisher","DOI":"10.1111\/acel.70410","volume":"25","author":"ML Goyer","year":"2026","unstructured":"Goyer, M. L. et al. The immunogenicity of human senescent cells is dependent on the senescence inducer and cell type. Aging Cell 25, e70410 (2026).","journal-title":"Aging Cell"}],"updated-by":[{"DOI":"10.1038\/s41577-026-01360-9","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T00:00:00Z","timestamp":1789603200000}}],"container-title":["Nature Reviews Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41577-026-01335-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41577-026-01335-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41577-026-01335-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T15:02:44Z","timestamp":1789657364000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41577-026-01335-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,11]]},"references-count":143,"alternative-id":["1335"],"URL":"https:\/\/doi.org\/10.1038\/s41577-026-01335-w","relation":{},"ISSN":["1474-1733","1474-1741"],"issn-type":[{"value":"1474-1733","type":"print"},{"value":"1474-1741","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,11]]},"assertion":[{"value":"2 July 2026","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 August 2026","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 September 2026","order":4,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":5,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"A Correction to this paper has been published:","order":6,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"https:\/\/doi.org\/10.1038\/s41577-026-01360-9","URL":"https:\/\/doi.org\/10.1038\/s41577-026-01360-9","order":7,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"P.G.-B. declares no competing interests. M.S. is listed as an inventor on a patent application related to senolytic therapies (WO 2025\/016917 A1). M.S. is a shareholder of Senolytic Therapeutics, Inc., Life Biosciences, Inc., Rejuveron Senescence Therapeutics AG and Altos Labs, Inc. The funders had no role in study design, decision to publish or preparation of the paper. C.A. is listed as the inventor of several patent applications (US 63\/985,407; 62\/800,188; 63\/174,277; 63\/209,941; 63\/209,940; 63\/209,915; 63\/209,924; 17\/426,728; 3,128,368; 20748891.7; 2020216486; 63\/510,997) related to senolytic CAR T cells.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Ethics"}}]}}